12
Participants
Start Date
August 31, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2014
Iray
The Oraya IRay stereotactic radiotherapy device will be used to deliver a 16 Gy dose of radiation to the macula. The radiotherapy will be delivered in a single session utilizing three sequential beams, each depositing 5.3 Gy at the macula through calculated scleral entry points, crossing the pars plana region of the eye, and overlapping at the same region of the macula.
Lucentis
Intravitreal injection of Lucentis as needed.
Università Vita-Salute Istituto Scientifico San Raffaele, Milan
Lead Sponsor
Oraya Therapeutics, Inc.
INDUSTRY